BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11439369)

  • 1. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
    J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
    Rocha AS; Soares P; Machado JC; Máximo V; Fonseca E; Franssila K; Sobrinho-Simões M
    Virchows Arch; 2002 May; 440(5):498-504. PubMed ID: 12021924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the cadherin-catenin complex in normal human thyroid epithelium and a thyroid carcinoma cell line.
    Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
    J Cell Biochem; 1998 Sep; 70(3):330-7. PubMed ID: 9706870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta- and gamma-catenin expression in thyroid carcinomas.
    Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
    J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
    Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
    Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
    Hiscox S; Jiang WG
    Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
    El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
    J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
    Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
    Hao X; Palazzo JP; Ilyas M; Tomlinson I; Talbot IC
    Anticancer Res; 1997; 17(3C):2241-7. PubMed ID: 9216695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
    El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
    Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin and catenins in invasive mammary carcinomas.
    Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
    Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
    Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
    J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
    Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
    Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
    J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.